Dysregulated miRNAs modulate tumor microenvironment associated signaling networks in pancreatic ductal adenocarcinoma
Precision Clinical Medicine · 03.03.2023 · 6 (1)
DOI: 10.1093/pcmedi/pbad004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Precision Clinical Medicine, online erschienen am 10.03.2023. Verfasst von Tiantian Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Genomics, School of Medicine, Loma Linda University, Loma Linda, CA 92350, USA. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health, American Heart Association.
Abstract (Originalsprache)
The desmoplastic and complex tumor microenvironment of pancreatic ductal adenocarcinoma (PDAC) has presented tremendous challenges for developing effective therapeutic strategies. Strategies targeting tumor stroma, albeit with great potential, have met with limited success due to the lack of knowledge on the molecular dynamics within the tumor microenvironment (TME). In pursuit of a better understanding of the influence of miRNAs on TME reprogramming and to explore circulating miRNAs as diagnostic and prognostic biomarkers for PDAC, using RNA-seq, miRNA-seq, and single-cell RNA-seq (scRNA-seq), we investigated the dysregulated signaling pathways in PDAC TME modulated by miRNAs from plasma and tumor tissue. Our bulk RNA-seq in PDAC tumor tissue identified 1445 significantly differentially expressed genes with extracellular matrix and structure organization as the top enriched pathways. Our miRNA-seq identified 322 and 49 abnormally expressed miRNAs in PDAC patient plasma and tumor tissue, respectively. We found many of the TME signaling pathways were targeted by those dysregulated miRNAs in PDAC plasma. Combined with scRNA-seq from patient PDAC tumor, our results revealed that these dysregulated miRNAs were closely associated with extracellular matrix (ECM) remodeling, cell-ECM communication, epithelial-mesenchymal transition, as well as immunosuppression orchestrated by different cellular components of TME. The findings of this study could assist the development of miRNA-based stromal targeting biomarkers or therapy for PDAC patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Genomics, School of Medicine, Loma Linda University, Loma Linda, CA 92350, USA.
- Transplant Institute, Loma Linda University, Loma Linda, CA 92350, USA.
- Cancer Center & School of Medicine, Loma Linda University, Loma Linda, CA 92350, USA.
- Department of Basic Sciences, School of Medicine, Loma Linda University, Loma Linda, CA 92350, USA.
ORCID-Profile: Charles Wang
Förderung
- NIH HHS
- National Institutes of Health
- American Heart Association
- Ardmore Institute of Health
Zitieren
APA
Liu, T., Chen, Z., Chen, W., Evans, R., Xu, J., Reeves, M. E., de Vera, M. E., & Wang, C. (2023). Dysregulated miRNAs modulate tumor microenvironment associated signaling networks in pancreatic ductal adenocarcinoma. Precision Clinical Medicine, 6(1). https://doi.org/10.1093/pcmedi/pbad004
Vancouver
Liu T, Chen Z, Chen W, Evans R, Xu J, Reeves ME, et al. Dysregulated miRNAs modulate tumor microenvironment associated signaling networks in pancreatic ductal adenocarcinoma. Precision Clinical Medicine. 2023;6(1). doi:10.1093/pcmedi/pbad004
BibTeX
@article{Liu2023,
author = {Liu, Tiantian and Chen, Zhong and Chen, Wanqiu and Evans, Ryan and Xu, Jane and Reeves, Mark E and de Vera, Michael E and Wang, Charles},
title = {Dysregulated miRNAs modulate tumor microenvironment associated signaling networks in pancreatic ductal adenocarcinoma},
journal = {Precision Clinical Medicine},
year = {2023},
volume = {6},
number = {1},
doi = {10.1093/pcmedi/pbad004}
}
EUVIMED